CEL-SCI Corporation - CVM

CVM Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CVM	3.7	-0.1	-1.7	-55.5	-66.1	-86.0	-93.4	-96.9	-97.7	-100.0
S&P 500	0.5	-0.8	3.2	6.4	9.9	25.3	34.5	88.2	200.4	34278.1

Compare CVM with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CVM
name	CEL-SCI Corporation
price	0.40
changes percentage	3.66
change	0.01
day low	0.38
day high	0.41
year high	3.08
year low	0.36
market cap	29605747
price avg 50	0.55
price avg 200	1.03
exchange	AMEX
volume	206411
avg volume	1066600
open	0.40
previous close	0.39
eps	-0.51
pe	-0.78
earnings announcement	2025-02-12T21:00:00.000+0000
shares outstanding	74107000
timestamp	2025-01-30 21:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 23.7%

Overall Quarterly Financial Health: 60.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000725363
revenue	0	0	NaN
gross profit	0	-3958334	100.00
gross profit ratio	0	0	NaN
research and development expenses	0	22471496	-100.00
operating expenses	0	31476074	-100.00
interest income	0	675.42	-100.00
interest expense	0	675416	-100.00
ebitda	0	-27560550	100.00
ebitdaratio	0	0	NaN
operating income	0	-31476074	100.00
operating income ratio	0	0	NaN
net income	0	-32365855.0	100.00
net income ratio	0	0	NaN
eps	-0.51	-0.73	30.14

Overall Score of Annual Income Statement

None

Detailed Analysis

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q3	Q/Q change %
0000725363
revenue	0	0	NaN
gross profit	0	-983208	100.00
gross profit ratio	0	0	NaN
research and development expenses	4477247	4703160	-4.80
operating expenses	6120404	6670235	-8.24
interest income	0	0	NaN
interest expense	174571	190705	-8.46
ebitda	-4943341	-5682647	13.01
ebitdaratio	0	0	NaN
operating income	-6120404	-6670235	8.24
operating income ratio	0	0	NaN
net income	-6109492	-6856558	10.90
net income ratio	0	0	NaN
eps	-0.11	-0.14	21.43

Overall Score of Quarterly Income Statement

0.43 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 0 million in 2024Q4 from -1 million in 2024Q3 representing a change of 100.0%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 6 million in 2024Q4 from 7 million in 2024Q3 representing a change of -8.24%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Earnings per Share (EPS): EPS increased to -0.11 in 2024Q4 from -0.11 in 2024Q3 representing a change of 21.43%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 4 million in 2024Q4 from 5 million in 2024Q3 representing a change of -4.8%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -5 million in 2024Q4 from -6 million in 2024Q3 representing a change of 13.01%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to -6 million in 2024Q4 from -7 million in 2024Q3 representing a change of 8.24%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -6 million in 2024Q4 from -7 million in 2024Q3 representing a change of 10.9%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000725363
total assets	26991766	30528250	-11.58
total liabilities	14124683	17313360	-18.42
total equity	12867083	13214890	-2.63
cash and cash equivalents	4738173	4145735	14.29
short term investments	0	4.24	-100.00
long term investments	0	0	NaN
total current assets	6055678	6918420	-12.47
total non current assets	20936088	23609830	-11.32
total current liabilities	4615779	5585846	-17.37
total non current liabilities	9508904	11727514	-18.92
common stock	637870	474223	34.51
retained earnings	-514011861	-487091396	-5.53
total debt	11621868	13571749	-14.37

Overall Score of Annual Balance Sheet

None

Detailed Analysis

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q3	Q/Q change %
0000725363
total assets	26991766	24068320	12.15
total liabilities	14124683	15595263	-9.43
total equity	12867083	8473057	51.86
cash and cash equivalents	4738173	384652	1,131.81
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	6055678	3542367	70.95
total non current assets	20936088	20525953	2.00
total current liabilities	4615779	5506341	-16.17
total non current liabilities	9508904	10088922	-5.75
common stock	637870	542578	17.56
retained earnings	-514011861	-507902369	-1.20
total debt	11621868	12132186	-4.21

Overall Score of Quarterly Balance Sheet

0.89 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 27 million in 2024Q4 from 24 million in 2024Q3 representing a change of 12.15%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 14 million in 2024Q4 from 16 million in 2024Q3 representing a change of -9.43%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 13 million in 2024Q4 from 8 million in 2024Q3 representing a change of 51.86%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 5 million in 2024Q4 from 0 million in 2024Q3 representing a change of 1131.81%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 6 million in 2024Q4 from 4 million in 2024Q3 representing a change of 70.95%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 5 million in 2024Q4 from 6 million in 2024Q3 representing a change of -16.17%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 1 in 2024Q4 from 1 in 2024Q3 representing a change of 17.56%. This indicates an increase in ownership interest.

  Total Debt: Total Debt decreased to 12 million in 2024Q4 from 12 million in 2024Q3 representing a change of -4.21%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Retained Earnings: Retained Earnings decreased to -514 million in 2024Q4 from -508 million in 2024Q3 representing a change of -1.2%. This indicates an accumulated losses.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000725363
net change in cash	592438	-18526403	103.20
operating cash flow	-18811206	-22848561	17.67
free cash flow	-18906081	-23220823	18.58
capital expenditure	-94875	-372262	74.51
depreciation and amortization	3969183	3958334	0.27
deferred income tax	0	0	NaN
stock based compensation	4270180	7149563	-40.27
accounts payables	-460576	257845	-278.63
inventory	0	-156727	100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-94875	-361892	73.78
net cash used for investing activites	-108086	-372262	70.97
debt repayment	-1773377	-1560455	-13.64
common stock issued	23655620	6552497	261.02
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	19511730	4694420	315.64
cash at end of period	4738173	4145735	14.29
accounts receivables	0	444780	-100.00
cash at beginning of period	4145735	22672138	-81.71

Overall Score of Annual Cashflow Statement

0.71 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 1 million in 2024 from -19 million in 2023 representing a change of 103.2%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to -19 million in 2024 from -23 million in 2023 representing a change of 17.67%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -19 million in 2024 from -23 million in 2023 representing a change of 18.58%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 4 million in 2024 from 7 million in 2023 representing a change of -40.27%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to 0 million in 2024 from 0 million in 2023 representing a change of -100.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to 0 million in 2024 from 0 million in 2023 representing a change of 74.51%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 0 million in 2024 from 0 million in 2023 representing a change of -278.63%. This indicates that the company has increased its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q3	Q/Q change %
0000725363
operating cash flow	-4816704	-4543893	-6.00
free cash flow	-4836457	-4567365	-5.89
capital expenditure	-19753	-23477	15.86
depreciation and amortization	991580	984208	0.75
deferred income tax	0	0	NaN
stock based compensation	861286	1019375	-15.51
accounts receivables	0	0	NaN
accounts payables	131794	304569	-56.73
inventory	131489	-64030	305.36
acquisitions net	0	0	NaN
investments in property plant and equipment	-19753	-23472	15.84
net cash used for investing activites	-19753	-23472	15.84
debt repayment	-458086	-448283	-2.19
common stock issued	10925620	45360	23,986.46
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	9189978	-322303	2,951.35
net change in cash	4353521	-4924669	188.40
cash at end of period	4738173	384652	1,131.81
cash at beginning of period	384652	5309321	-92.76

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 4 million in 2024Q4 from -5 million in 2024Q3 representing a change of 188.4%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Stock-Based Compensation: Stock-Based Compensation decreased to 1 million in 2024Q4 from 1 million in 2024Q3 representing a change of -15.51%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q4 from 0 million in 2024Q3 representing a change of -56.73%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to -5 million in 2024Q4 from -5 million in 2024Q3 representing a change of -6.0%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -5 million in 2024Q4 from -5 million in 2024Q3 representing a change of -5.89%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to 0 million in 2024Q4 from 0 million in 2024Q3 representing a change of 15.86%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-09-30	2023-09-30	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	0	0	NaN
net income per share	0	-0.73	100.00
operating cash flow per share	-0.35	-0.51	32.24
free cash flow per share	-0.35	-0.52	32.99
cash per share	0.09	0.09	-5.94
book value per share	0.24	0.3	-19.86
tangible book value per share	0.24	0.29	-19.69
shareholders equity per share	0.24	0.3	-19.86
interest debt per share	0.22	0.32	-32.86
market cap	57287688.34	55599831.25	3.04
enterprise value	64171383.34	65025845.25	-1.31
pe ratio	0	-1.72	100.00
price to sales ratio	0	0	NaN
pocfratio	-3.05	-2.43	-25.15
pfcf ratio	-3.03	-2.39	-26.55
pb ratio	4.45	4.21	5.82
ptb ratio	4.45	4.21	5.82
ev to sales	0	0	NaN
enterprise value over ebitda	0	-2.36	100.00
ev to operating cash flow	-3.41	-2.85	-19.87
ev to free cash flow	-3.39	-2.8	-21.21
earnings yield	0	-0.58	100.00
free cash flow yield	-0.33	-0.42	20.98
debt to equity	0.9	1.03	-12.05
debt to assets	0.43	0.44	-3.15
net debt to ebitda	0	-0.34	100.00
current ratio	1.31	1.24	5.93
interest coverage	0	-46.6	100.00
income quality	0.7	0.71	-1.54
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.01	0.01	-5.33
capex to operating cash flow	-0.01	-0.02	69.04
capex to revenue	0	0	NaN
capex to depreciation	0.02	0.09	-74.58
stock based compensation to revenue	0	0	NaN
graham number	0	2.21	-100.00
roic	None	-1.17	NaN
return on tangible assets	0	-1.07	100.00
graham net net	-0.17	-0.27	35.86
working capital	1439899	1332574	8.05
tangible asset value	12701591	13017186	-2.42
net current asset value	-8069005	-10394940	22.38
invested capital	18581445	22548634	-17.59
average receivables	0	0	NaN
average payables	1729126.5	1814038	-4.68
average inventory	1124036	2124893.5	-47.10
days sales outstanding	0	0	NaN
days payables outstanding	0	185.32	-100.00
days of inventory on hand	0	207.3	-100.00
receivables turnover	0	0	NaN
payables turnover	0	1.97	-100.00
inventory turnover	0	1.76	-100.00
roe	0	-2.45	100.00
capex per share	0.0	0.01	-79.02

• Negative

  ROE: Return on Equity (ROE) increased to 0.00 on 2024-09-30 from -2.45 on 2023-09-30, representing a change of 100.00%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 0.00 on 2024-09-30 from -1.72 on 2023-09-30, representing a change of 100.00%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.31 on 2024-09-30 from 1.24 on 2023-09-30, representing a change of 5.93%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.90 on 2024-09-30 from 1.03 on 2023-09-30, representing a change of -12.05%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q4	2024-06-30 Q3	Q/Q change %
CVM
calendar year	2024	2024	NaN
revenue per share	0	0	NaN
net income per share	-0.11	-0.13	10.98
operating cash flow per share	-0.09	-0.08	-5.90
free cash flow per share	-0.09	-0.08	-5.79
cash per share	0.09	0.01	1,130.65
book value per share	0.24	0.16	51.72
tangible book value per share	0.24	0.15	52.89
shareholders equity per share	0.24	0.16	51.72
interest debt per share	0.22	0.23	-4.36
market cap	57287688.34	61013653.92	-6.11
enterprise value	64171383.34	72761187.92	-11.81
pe ratio	-2.34	-2.22	-5.37
price to sales ratio	0	0	NaN
pocfratio	-11.89	-13.43	11.42
pfcf ratio	-11.84	-13.36	11.33
pb ratio	4.45	7.2	-38.17
ptb ratio	4.45	7.2	-38.17
ev to sales	0	0	NaN
enterprise value over ebitda	-12.98	-12.8	-1.38
ev to operating cash flow	-13.32	-16.01	16.80
ev to free cash flow	-13.27	-15.93	16.71
earnings yield	-0.11	-0.11	5.10
free cash flow yield	-0.08	-0.07	-12.78
debt to equity	0.9	1.43	-36.92
debt to assets	0.43	0.5	-14.58
net debt to ebitda	-1.39	-2.07	32.64
current ratio	1.31	0.64	103.93
interest coverage	-35.06	-34.98	-0.24
income quality	0.79	0.66	18.97
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.01	0.01	-14.71
capex to operating cash flow	-0.0	-0.01	20.63
capex to revenue	0	0	NaN
capex to depreciation	0.02	0.02	-16.49
stock based compensation to revenue	0	0	NaN
graham number	0.78	0.67	16.22
roic	-0.25	-0.29	14.64
return on tangible assets	-0.23	-0.29	20.63
graham net net	-0.16	-0.26	36.35
working capital	1439899	-1963974	173.32
tangible asset value	12701591	8300029	53.03
net current asset value	-8069005	-12052896	33.05
invested capital	18581445	16171289	14.90
average receivables	0	0	NaN
average payables	1408954	1192705	18.13
average inventory	1787578.5	2522266.5	-29.13
days sales outstanding	0	0	NaN
days payables outstanding	0	125.35	-100.00
days of inventory on hand	0	233.9	-100.00
receivables turnover	0	0	NaN
payables turnover	0	0.72	-100.00
inventory turnover	0	0.38	-100.00
roe	-0.47	-0.81	41.32
capex per share	0.0	0.0	-15.94

• Negative

  ROE: Return on Equity (ROE) increased to -0.47 on 2024-09-30 Q4 from -0.81 on 2024-06-30 Q3, representing a change of 41.32%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -2.34 on 2024-09-30 Q4 from -2.22 on 2024-06-30 Q3, representing a change of -5.37%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.31 on 2024-09-30 Q4 from 0.64 on 2024-06-30 Q3, representing a change of 103.93%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.90 on 2024-09-30 Q4 from 1.43 on 2024-06-30 Q3, representing a change of -36.92%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is -0.13 which is lower than current price 0.4, indicates the company may be overvalued.